Facial Angiofibromas
📧 Sign up to get email alerts when something new happens for Facial Angiofibromas.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-03-22FDA Approved: HYFTOR — Original Application (Nobelpharma America, LLC)
FDA approved HYFTOR (sirolimus) under an original application from Nobelpharma America, expanding treatment options with a topical sirolimus…
-
CLINICAL_TRIALS withdrawal · 2021-05-03Clinical Trial Update: Topical Everolimus in Patients With Tuberous Sclerosis Complex [Phase 2, Phase 3]
A clinical trial for topical everolimus in facial angiofibromas associated with tuberous sclerosis complex was withdrawn.